Skip to Content

Answers (1)

Official Answer by 22 Jan 2018

Ixifi (infliximab-qbtx), from Pfizer, is an FDA-approved tumor necrosis factor (TNF) blocker that is biosimilar to Remicade (infliximab), from Janssen Biotech. Both prescription medications are used for the treatment of Crohn’s disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and plaque psoriasis. Biosimilars are approved through an abbreviated licensure pathway for biological products that are shown to be interchangeable with an already FDA-approved biological product.

What drugs are biosimilar to Remicade?

In addition to Ixifi (infliximab-qbtx), Inflectra (infliximab-dyyb) from Pfizer and Renflexis (infliximab-abda) from Merck are also FDA-approved biosimilars to Remicade; however, none of these biosimilars are interchangeable at the pharmacy level with Remicade unless specifically noted by the prescribing doctor. free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

What type of drug is Motegrity?

Updated 14 days ago 1 answerFAQ by

What disease is Elzonris (tagraxofusp-erzs) used to treat?

Updated 11 days ago 1 answerFAQ by

How do you use the ProAir Digihaler?

Updated 11 days ago 1 answerFAQ by

How many biosimilars have been approved in the United States?

Updated 10 days ago 1 answerFAQ by